Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort [3]

Annals of the Rheumatic Diseases

Volumn 66, Issue 11, 2007, Pages 1543-1544

  Turesson, Carl ^a   Eberhardt, K ^a   Jacobsson, L T H ^a   Lindqvist, E ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; ELECTROIMMUNOASSAY; EPISCLERITIS; FELTY SYNDROME; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; INCIDENCE; INTERSTITIAL LUNG DISEASE; LETTER; MORBIDITY; PERICARDITIS; PERIPHERAL NEUROPATHY; PLEURISY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCLERITIS; VASCULITIS;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 35648948992     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.076521     Document Type: Letter

References (10)

1. Lindqvist E, Saxne T, Geborek P, Eberhardt K. Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage. Ann Rheum Dis 2002;61:1055-9.
2. Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 2004;33:65-72.
3. Johnson U, Truedsson L, Gustavii B. Complement components in 100 newborns and their mothers determined by electroimmunoassay. Acta Pathol Microbiol Immunol Scand 1983;91:147-50.
4. Turesson C, O'Fallon WM, Crowson CS, et al. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62-7.
5. Watts RA, Mooney J, Lane SE, Scott DG. Rheumatoid vasculitis: becoming extinct? Rheumatology (Oxford) 2004;43:920-3.
6. Ward MM. Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001. Arthritis Rheum 2004;50:1122-31.
7. Turesson C, McClelland RL, Christianson TJ, Matteson EL. No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study. Arthritis Rheum 2004;50:3729-31.
8. Ritchie RF, Palomaki GE, Neveux LM, et al. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 2004;18:1-8.
9. Scott DG, Bacon PA, Allen C, et al. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol 1981;43:54-63.
10. Melsom RD, Horsfall AC, Schrieber L, et al. Anti-C1q affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease. Rheumatol Int 1986;6:227-31.